301 related articles for article (PubMed ID: 7608265)
21. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.
Alos N; Moisan AM; Ward L; Desrochers M; Legault L; Leboeuf G; Van Vliet G; Simard J
J Clin Endocrinol Metab; 2000 May; 85(5):1968-74. PubMed ID: 10843183
[TBL] [Abstract][Full Text] [Related]
22. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
[TBL] [Abstract][Full Text] [Related]
23. Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females.
Mendonça BB; Russell AJ; Vasconcelos-Leite M; Arnhold IJ; Bloise W; Wajchenberg BL; Nicolau W; Sutcliffe RG; Wallace AM
J Mol Endocrinol; 1994 Feb; 12(1):119-22. PubMed ID: 8185809
[TBL] [Abstract][Full Text] [Related]
24. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
25. Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
Welzel M; Wüstemann N; Simic-Schleicher G; Dörr HG; Schulze E; Shaikh G; Clayton P; Grötzinger J; Holterhus PM; Riepe FG
J Clin Endocrinol Metab; 2008 Apr; 93(4):1418-25. PubMed ID: 18252794
[TBL] [Abstract][Full Text] [Related]
26. Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family.
Simard J; Sanchez R; Durocher F; Rhéaume E; Turgeon C; Labrie Y; Luu-The V; Mebarki F; Morel Y; de Launoit Y
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):489-505. PubMed ID: 8547174
[TBL] [Abstract][Full Text] [Related]
27. Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity.
Lachance Y; Luu-The V; Verreault H; Dumont M; Rhéaume E; Leblanc G; Labrie F
DNA Cell Biol; 1991 Dec; 10(10):701-11. PubMed ID: 1741954
[TBL] [Abstract][Full Text] [Related]
28. Serine 124 completes the Tyr, Lys and Ser triad responsible for the catalysis of human type 1 3beta-hydroxysteroid dehydrogenase.
Thomas JL; Duax WL; Addlagatta A; Scaccia LA; Frizzell KA; Carloni SB
J Mol Endocrinol; 2004 Aug; 33(1):253-61. PubMed ID: 15291757
[TBL] [Abstract][Full Text] [Related]
29. A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase.
Clarke TR; Bain PA; Greco TL; Payne AH
Mol Endocrinol; 1993 Dec; 7(12):1569-78. PubMed ID: 8145763
[TBL] [Abstract][Full Text] [Related]
30. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
[TBL] [Abstract][Full Text] [Related]
31. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin.
Simard J; Rhéaume E; Leblanc JF; Wallis SC; Joplin GF; Gilbey S; Allanson J; Mettler G; Bettendorf M; Heinrich U
Hum Mol Genet; 1994 Feb; 3(2):327-30. PubMed ID: 8004103
[TBL] [Abstract][Full Text] [Related]
32. A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.
Marui S; Torrealba IM; Russell AJ; Latronico AC; Sutcliffe RG; Mendonca BB
Hum Mutat; 1998; 12(2):139. PubMed ID: 10694926
[TBL] [Abstract][Full Text] [Related]
33. Regulation of 3-ketosteroid reductase messenger ribonucleic acid levels and 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in rat liver by sex steroids and pituitary hormones.
Couet J; Simard J; Martel C; Trudel C; Labrie Y; Labrie F
Endocrinology; 1992 Dec; 131(6):3034-44. PubMed ID: 1446638
[TBL] [Abstract][Full Text] [Related]
34. The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.
Can S; Zhu YS; Cai LQ; Ling Q; Katz MD; Akgun S; Shackleton CH; Imperato-McGinley J
J Clin Endocrinol Metab; 1998 Feb; 83(2):560-9. PubMed ID: 9467575
[TBL] [Abstract][Full Text] [Related]
35. Regulation of expression of male-specific rat liver microsomal 3 beta-hydroxysteroid dehydrogenase.
Naville D; Keeney DS; Jenkin G; Murry BA; Head JR; Mason JI
Mol Endocrinol; 1991 Aug; 5(8):1090-100. PubMed ID: 1944305
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the structure-activity relationships of rat types I and II 3 beta-hydroxysteroid dehydrogenase/delta 5 -delta 4 isomerase by site-directed mutagenesis and expression in HeLa cells.
Simard J; de Launoit Y; Labrie F
J Biol Chem; 1991 Aug; 266(23):14842-5. PubMed ID: 1831194
[TBL] [Abstract][Full Text] [Related]
37. The human 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3 beta-HSD and CYP17 do not segregate with dominantly inherited hirsutism.
McBride MW; Russell AJ; Vass K; Frank-Raue K; Craig NJ; Morrison N; Boyd E; Szpirer C; Sutcliffe RG
J Mol Endocrinol; 1995 Oct; 15(2):167-76. PubMed ID: 8800641
[TBL] [Abstract][Full Text] [Related]
38. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
[TBL] [Abstract][Full Text] [Related]
39. Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase.
Thomas JL; Duax WL; Addlagatta A; Kacsoh B; Brandt SE; Norris WB
Mol Cell Endocrinol; 2004 Feb; 215(1-2):73-82. PubMed ID: 15026177
[TBL] [Abstract][Full Text] [Related]
40. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity.
Thomas JL; Mason JI; Brandt S; Spencer BR; Norris W
J Biol Chem; 2002 Nov; 277(45):42795-801. PubMed ID: 12205101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
